MADISON, Wis., Dec. 1, 2014 (GLOBE NEWSWIRE) — Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL) today announced that Chief Operating Officer Emile Nuwaysir will participate in the Piper Jaffray 26th Annual Healthcare Conference to be held December 2-3 in New York City.
The following are specific details regarding CDI’s participation:
||Tuesday, December 2, 2014
||4:00 p.m. ET
||New York Palace Hotel, New York City
||The live audio webcast can be accessed via the Investor Relations section of CDI’s website at investors.cellulardynamics.com within Events & Presentations.
||The archived audio webcast will be available on the Company’s website for approximately one year following the presentation.
About Cellular Dynamics International, Inc.
Cellular Dynamics International, Inc. (CDI) is a leading developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications. CDI’s proprietary iCell Operating System (iCell O/S) includes true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI’s iCell O/S products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our iCell O/S products, among other purposes, for drug discovery and screening; to test the safety and efficacy of their small molecule and biologic drug candidates; for stem cell banking; and in the research and development of cellular therapeutics. CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin–Madison. CDI’s facilities are located in Madison, Wisconsin, with a second facility in Novato, California. See www.cellulardynamics.com.
Senior Director, Marketing & Communications
Cellular Dynamics International, Inc.
Gitanjali Jain Ogawa
The Trout Group, LLC
Source: Cellular Dynamics International, Inc.
News Provided by Acquire Media